POCS in Liver Transplantation Patients



Status:Recruiting
Healthy:No
Age Range:18 - Any
Updated:3/31/2019
Start Date:January 25, 2018
End Date:August 2020
Contact:Srey Yin
Email:srey.yin@bsci.com
Phone:508-683-4162

Use our guide to learn which trials are right for you!

Per-Oral Cholangioscopy in Liver Transplantation Patients

A prospective, multi-center, non-randomized, observational, consecutive case series, which
will compare Endoscopic Retrograde Cholangiopancreatoscopy (ERCP) and cholangioscopy with Spy
Glass Digital System (DS) procedure at 5-10 centers.

The objective of this study is to demonstrate the clinical utility of cholangioscopy with Spy
Glass Digital System (DS) in cadaveric donor or live donor liver transplantation patients who
are referred for ERCP in the setting of a clinical suspicion of post liver transplant bile
duct stricture(s). A secondary study objective is to generate a hypothesis for a randomized
controlled trial comparing ERCP alone to ERCP with Per- Oral Cholangioscopy (POCS) in
patients referred for ERCP post liver transplantation.

Inclusion Criteria:

1. Liver transplantation at least 1 month prior to POCS procedure

2. Abnormal Liver Function Tests (LFTs) and/or biliary obstructive symptoms

3. Prior cross sectional imaging (MRI and/or US and/or CT)

4. Suspicion of anastomotic biliary stricture(s)

5. Diameter of bile ducts deemed sufficient to accommodate cholangioscopy system based on
baseline imaging

6. Willing and able to provide a written informed consent to participate in the study

7. Willing and able to comply with study procedures and follow-up schedule

Exclusion Criteria:

1. Contraindication for an ERCP per local standard of practice

2. Deemed contraindicated for POCS per local standard of practice

3. Prior biliary treatment of biliary anastomotic stricture

4. < 18 years old

5. Documented life expectancy of less than 12 months.
We found this trial at
3
sites
200 Lothrop St
Pittsburgh, Pennsylvania 15213
Principal Investigator: Adam Slivka, MD, PhD
Phone: 412-647-8132
University of Pittsburgh Medical Center UPMC is one of the leading nonprofit health systems in...
?
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
630 West 168th Street
New York, New York 10032
Principal Investigator: Amrita Sethi, MD
Phone: 212-305-2862
?
mi
from
New York, NY
Click here to add this to my saved trials
São Paulo, 05403
Principal Investigator: Eduardo De Moura, MD
?
mi
from
São Paulo,
Click here to add this to my saved trials